APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Morphine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Morphine Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchMedical Morphine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Morphine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Medical Morphine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Morphine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Morphine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Medical Morphine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Morphine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Morphine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Morphine market include Sun Pharmaceutical Industries, Pfizer, Taj Pharmaceuticals Limited, Purdue Pharma, Mallinckrodt Pharmaceuticals and Alcaliber, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Morphine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Morphine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Morphine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Morphine market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Morphine Segment by Company

Sun Pharmaceutical Industries

Pfizer

Taj Pharmaceuticals Limited

Purdue Pharma

Mallinckrodt Pharmaceuticals

Alcaliber

Medical Morphine Segment by Type

Oral

Injectables

Medical Morphine Segment by Application

Cancer

Arthritis

Medical Morphine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Morphine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Morphine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Morphine significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Morphine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Morphine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Morphine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Morphine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Morphine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Morphine industry.

Chapter 3: Detailed analysis of Medical Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Morphine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Morphine Industry Trends Table 2. Medical Morphine Industry Drivers Table 3. Medical Morphine Industry Opportunities and Challenges Table 4. Medical Morphine Industry Restraints Table 5. Global Medical Morphine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Morphine Revenue Share by Company (2021-2026) Table 7. Global Medical Morphine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Medical Morphine Sales Volume Share by Company (2021-2026) Table 9. Global Medical Morphine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Medical Morphine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Morphine Key Company Manufacturing Base & Headquarters Table 12. Global Medical Morphine Company, Product Type & Application Table 13. Global Medical Morphine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Morphine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Injectables Table 19. Global Medical Morphine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Medical Morphine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Medical Morphine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Medical Morphine Sales Volume Share by Type (2021-2026) Table 23. Global Medical Morphine Sales Volume Share by Type (2027-2032) Table 24. Global Medical Morphine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Medical Morphine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Medical Morphine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Medical Morphine Sales Value Share by Type (2021-2026) Table 28. Global Medical Morphine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cancer Table 30. Significant Companies of Arthritis Table 31. Global Medical Morphine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Medical Morphine Sales Volume by Application (2021-2026) & (k units) Table 33. Global Medical Morphine Sales Volume by Application (2027-2032) & (k units) Table 34. Global Medical Morphine Sales Volume Share by Application (2021-2026) Table 35. Global Medical Morphine Sales Volume Share by Application (2027-2032) Table 36. Global Medical Morphine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Medical Morphine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Medical Morphine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Medical Morphine Sales Value Share by Application (2021-2026) Table 40. Global Medical Morphine Sales Value Share by Application (2027-2032) Table 41. Global Medical Morphine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Medical Morphine Sales by Region (2021-2026) & (k units) Table 43. Global Medical Morphine Sales Market Share by Region (2021-2026) Table 44. Global Medical Morphine Sales by Region (2027-2032) & (k units) Table 45. Global Medical Morphine Sales Market Share by Region (2027-2032) Table 46. Global Medical Morphine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Medical Morphine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Medical Morphine Sales Value Share by Region (2021-2026) Table 49. Global Medical Morphine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Medical Morphine Sales Value Share by Region (2027-2032) Table 51. Global Medical Morphine Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Medical Morphine Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Medical Morphine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Medical Morphine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Medical Morphine Sales by Country (2021-2026) & (k units) Table 56. Global Medical Morphine Sales Market Share by Country (2021-2026) Table 57. Global Medical Morphine Sales by Country (2027-2032) & (k units) Table 58. Global Medical Morphine Sales Market Share by Country (2027-2032) Table 59. Global Medical Morphine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Medical Morphine Sales Value Market Share by Country (2021-2026) Table 61. Global Medical Morphine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Medical Morphine Sales Value Market Share by Country (2027-2032) Table 63. Sun Pharmaceutical Industries Company Information Table 64. Sun Pharmaceutical Industries Business Overview Table 65. Sun Pharmaceutical Industries Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Industries Medical Morphine Product Portfolio Table 67. Sun Pharmaceutical Industries Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Pfizer Medical Morphine Product Portfolio Table 72. Pfizer Recent Development Table 73. Taj Pharmaceuticals Limited Company Information Table 74. Taj Pharmaceuticals Limited Business Overview Table 75. Taj Pharmaceuticals Limited Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Taj Pharmaceuticals Limited Medical Morphine Product Portfolio Table 77. Taj Pharmaceuticals Limited Recent Development Table 78. Purdue Pharma Company Information Table 79. Purdue Pharma Business Overview Table 80. Purdue Pharma Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Purdue Pharma Medical Morphine Product Portfolio Table 82. Purdue Pharma Recent Development Table 83. Mallinckrodt Pharmaceuticals Company Information Table 84. Mallinckrodt Pharmaceuticals Business Overview Table 85. Mallinckrodt Pharmaceuticals Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolio Table 87. Mallinckrodt Pharmaceuticals Recent Development Table 88. Alcaliber Company Information Table 89. Alcaliber Business Overview Table 90. Alcaliber Medical Morphine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Alcaliber Medical Morphine Product Portfolio Table 92. Alcaliber Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Medical Morphine Distributors List Table 96. Medical Morphine Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Medical Morphine Product Image Figure 2. Global Medical Morphine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Morphine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Morphine Sales (2021-2032) & (k units) Figure 5. Global Medical Morphine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Medical Morphine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Injectables Image Figure 11. Global Medical Morphine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Medical Morphine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Medical Morphine Sales Volume Share by Type (2021-2032) Figure 14. Global Medical Morphine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Medical Morphine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Medical Morphine Sales Value Share by Type (2021-2032) Figure 17. Cancer Image Figure 18. Arthritis Image Figure 19. Global Medical Morphine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Medical Morphine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Medical Morphine Sales Volume Share by Application (2021-2032) Figure 22. Global Medical Morphine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Medical Morphine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Medical Morphine Sales Value Share by Application (2021-2032) Figure 25. Global Medical Morphine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Medical Morphine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Medical Morphine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Medical Morphine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Medical Morphine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Medical Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Medical Morphine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Medical Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Medical Morphine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Medical Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Medical Morphine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Medical Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Medical Morphine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Medical Morphine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Medical Morphine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Medical Morphine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Medical Morphine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Medical Morphine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Medical Morphine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectables
Applications
  • Cancer
  • Arthritis
Companies covered
  • Sun Pharmaceutical Industries
  • Pfizer
  • Taj Pharmaceuticals Limited
  • Purdue Pharma
  • Mallinckrodt Pharmaceuticals
  • Alcaliber

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Morphine Sales Value (2021-2032)
  4. 1.2.2 Global Medical Morphine Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Morphine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Morphine Market Dynamics
  1. 2.1 Medical Morphine Industry Trends
  2. 2.2 Medical Morphine Industry Drivers
  3. 2.3 Medical Morphine Industry Opportunities and Challenges
  4. 2.4 Medical Morphine Industry Restraints
3 Medical Morphine Market by Company
  1. 3.1 Global Medical Morphine Company Revenue Ranking in 2025
  2. 3.2 Global Medical Morphine Revenue by Company (2021-2026)
  3. 3.3 Global Medical Morphine Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Morphine Average Price by Company (2021-2026)
  5. 3.5 Global Medical Morphine Company Ranking (2024-2026)
  6. 3.6 Global Medical Morphine Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Morphine Company Product Type and Application
  8. 3.8 Global Medical Morphine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Morphine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Morphine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Morphine Market by Type
  1. 4.1 Medical Morphine Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injectables
  4. 4.2 Global Medical Morphine Sales Volume by Type
  5. 4.2.1 Global Medical Morphine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Medical Morphine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Medical Morphine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Medical Morphine Sales Value by Type
  9. 4.3.1 Global Medical Morphine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Medical Morphine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Medical Morphine Sales Value Share by Type (2021-2032)
5 Medical Morphine Market by Application
  1. 5.1 Medical Morphine Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Arthritis
  4. 5.2 Global Medical Morphine Sales Volume by Application
  5. 5.2.1 Global Medical Morphine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Medical Morphine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Medical Morphine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Medical Morphine Sales Value by Application
  9. 5.3.1 Global Medical Morphine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Medical Morphine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Medical Morphine Sales Value Share by Application (2021-2032)
6 Medical Morphine Regional Sales and Value Analysis
  1. 6.1 Global Medical Morphine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Morphine Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Morphine Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Morphine Sales by Region (2027-2032)
  5. 6.3 Global Medical Morphine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Morphine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Morphine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Morphine Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Morphine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Morphine Sales Value (2021-2032)
  12. 6.6.2 North America Medical Morphine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Morphine Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Morphine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Morphine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Morphine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Morphine Sales Value (2021-2032)
  21. 6.9.2 South America Medical Morphine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Morphine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Morphine Sales Value Share by Country, 2025 VS 2032
7 Medical Morphine Country-level Sales and Value Analysis
  1. 7.1 Global Medical Morphine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Morphine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Morphine Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Morphine Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Morphine Sales by Country (2027-2032)
  6. 7.4 Global Medical Morphine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Morphine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Morphine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Morphine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Morphine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Morphine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Morphine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Morphine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Morphine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Morphine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Morphine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Morphine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Morphine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Morphine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Morphine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Morphine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Morphine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Morphine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Morphine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Morphine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Morphine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Morphine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Morphine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Morphine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Morphine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Morphine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Morphine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Morphine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Morphine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Morphine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Morphine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Morphine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Morphine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Morphine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Morphine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Morphine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Morphine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Morphine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Morphine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Morphine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Morphine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Morphine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Morphine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Morphine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Morphine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Morphine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Morphine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Morphine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Morphine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Morphine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Morphine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Morphine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Morphine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Morphine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Morphine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Morphine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Morphine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Morphine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Morphine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Morphine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Morphine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Morphine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Morphine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Morphine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Morphine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Morphine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Morphine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Morphine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Morphine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Morphine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Morphine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Morphine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Morphine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Morphine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Morphine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Morphine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Morphine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Morphine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Morphine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Morphine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Morphine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Morphine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Morphine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Morphine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Morphine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Morphine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Morphine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Medical Morphine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Medical Morphine Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Medical Morphine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Medical Morphine Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Taj Pharmaceuticals Limited
  14. 8.3.1 Taj Pharmaceuticals Limited Company Information
  15. 8.3.2 Taj Pharmaceuticals Limited Business Overview
  16. 8.3.3 Taj Pharmaceuticals Limited Medical Morphine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Taj Pharmaceuticals Limited Medical Morphine Product Portfolio
  18. 8.3.5 Taj Pharmaceuticals Limited Recent Developments
  19. 8.4 Purdue Pharma
  20. 8.4.1 Purdue Pharma Company Information
  21. 8.4.2 Purdue Pharma Business Overview
  22. 8.4.3 Purdue Pharma Medical Morphine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Purdue Pharma Medical Morphine Product Portfolio
  24. 8.4.5 Purdue Pharma Recent Developments
  25. 8.5 Mallinckrodt Pharmaceuticals
  26. 8.5.1 Mallinckrodt Pharmaceuticals Company Information
  27. 8.5.2 Mallinckrodt Pharmaceuticals Business Overview
  28. 8.5.3 Mallinckrodt Pharmaceuticals Medical Morphine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolio
  30. 8.5.5 Mallinckrodt Pharmaceuticals Recent Developments
  31. 8.6 Alcaliber
  32. 8.6.1 Alcaliber Company Information
  33. 8.6.2 Alcaliber Business Overview
  34. 8.6.3 Alcaliber Medical Morphine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Alcaliber Medical Morphine Product Portfolio
  36. 8.6.5 Alcaliber Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Morphine Value Chain Analysis
  2. 9.1.1 Medical Morphine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Morphine Sales Mode & Process
  6. 9.2 Medical Morphine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Morphine Distributors
  9. 9.2.3 Medical Morphine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst